The patient was diagnosed with a rare and life-threatening condition that required him to undergo a two-hour surgery. Without ...

That was a modest wager on a drug that stood a chance of becoming the first FDA-approved topical therapy for congenital ichthyosis, a collection of around 20 rare skin disorders that cause dry ...

Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid. If approved, Dupixent would be the first and only targeted medicine to treat BP in ...

German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening ... treat other skin diseases, such as palmoplantar ...

University of Ferrara researchers in Italy have examined how European skin, eye and hair pigmentation evolved over the past ...

(NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent ® ...

One might object, arguing that having a ruach hakodesh perception of one’s soul gender is not the same as self-perception, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

By the time the girl was admitted to hospital, her hair was brittle, her skin was flaking, and she was so malnourished that ...

A doctor has issued a serious warning to anyone who bites their nails after one woman contracted a ‘deadly infection’.

More than 30 million people in the United States are affected by rare diseases, many of which are life-threatening conditions ...